Ocular symptoms and signs with preserved and preservative-free glaucoma medications
- PMID: 17534814
- DOI: 10.1177/112067210701700311
Ocular symptoms and signs with preserved and preservative-free glaucoma medications
Abstract
Purpose: To compare the prevalence of side effects between eyedrops with or without preservatives, in terms of subjective symptoms and objective signs in patients with open-angle glaucoma.
Methods: In a multicenter cross-sectional epidemiologic survey in four European countries, ophthalmologists in private practice enrolled 9658 nonconsecutive patients using preservative (P) or preservative-free (PF) beta-blocking eyedrops between June 1997 and December 2003. Subjective symptoms, conjunctival and palpebral signs, and superficial punctate keratitis were explored before and after a change in therapy. For statistical analysis, a Chi-square test was used to calculate the differences in the prevalence of symptoms and signs with or without preservatives.
Results: A total of 74% of the patients used P, 12% PF, 10% a P-PF combination, and in 4% the type of medication was unknown. Each recorded symptom and all the palpebral, conjunctival, and corneal signs were significantly more frequent (p<0.0001) in the P-group than in the PF-group, such as pain or discomfort during instillation (48 vs 19%), foreign body sensation (42 vs 15%), stinging or burning (48 vs 20%), and dry eye sensation (35 vs 16%). A total of 68% of the patients had a sec-ond visit performed, of whom 63% (6083) had been evaluated on treatment difference. A significant decrease (p<0.0001) of all ocular symptoms and signs was observed in patients in whom the preserved eyedrops were diminished in number or altered into preservative free drops.
Conclusions: Compared to preserved eyedrops, preservative free eyedrops are significantly less associated with ocular symptoms and signs of irritation.
Similar articles
-
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.Br J Ophthalmol. 2002 Apr;86(4):418-23. doi: 10.1136/bjo.86.4.418. Br J Ophthalmol. 2002. PMID: 11914211 Free PMC article.
-
[Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe].J Fr Ophtalmol. 1999 Mar;22(2):186-91. J Fr Ophtalmol. 1999. PMID: 10327349 French.
-
Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.Optom Vis Sci. 2015 Sep;92(9):e222-6. doi: 10.1097/OPX.0000000000000542. Optom Vis Sci. 2015. PMID: 25730335
-
PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE.Rom J Ophthalmol. 2015 Jan-Mar;59(1):2-5. Rom J Ophthalmol. 2015. PMID: 27373107 Free PMC article. Review.
-
Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.Acta Ophthalmol. 2008 Nov;86(7):716-26. doi: 10.1111/j.1755-3768.2008.01250.x. Epub 2008 Jun 3. Acta Ophthalmol. 2008. PMID: 18537937 Review.
Cited by
-
Managing Ocular Surface Disease in Glaucoma Treatment: A Systematic Review.Bioengineering (Basel). 2024 Oct 11;11(10):1010. doi: 10.3390/bioengineering11101010. Bioengineering (Basel). 2024. PMID: 39451386 Free PMC article. Review.
-
Prevalence of Ocular Surface Disease and Associated Risk Factors in Glaucoma Patients: A Survey Study of Ophthalmologists.Turk J Ophthalmol. 2022 Oct 28;52(5):302-308. doi: 10.4274/tjo.galenos.2021.20726. Turk J Ophthalmol. 2022. PMID: 36317767 Free PMC article.
-
Efficacy of treatments for neurotrophic keratopathy: a systematic review and meta-analysis.Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2623-2637. doi: 10.1007/s00417-022-05602-z. Epub 2022 Mar 7. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35254511
-
Anti-glaucoma agents-induced pseudodendritic keratitis presumed to be herpetic simplex keratitis: a clinical case series.Sci Rep. 2021 Nov 2;11(1):21443. doi: 10.1038/s41598-021-01073-0. Sci Rep. 2021. PMID: 34728756 Free PMC article.
-
Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases.BMC Ophthalmol. 2011 Jun 14;11:14. doi: 10.1186/1471-2415-11-14. BMC Ophthalmol. 2011. PMID: 21672240 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical